Kinesio-Taping vs. Usual Care for Malignant Bowel Obstruction With Ascites
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Jun 8, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether abdominal Kinesio-taping can help relieve symptoms like pain, bloating, and nausea in adults with advanced cancer who have malignant bowel obstruction and ascites (fluid buildup in the abdomen). These patients often continue to experience severe symptoms even after receiving standard medical treatments. The trial aims to find out if Kinesio-taping is a safe and effective option to help improve their quality of life.
To participate in this study, individuals must be at least 18 years old, have a confirmed diagnosis of cancer affecting the abdomen, and continue to suffer from severe symptoms after other treatments. Participants will be randomly assigned to either receive Kinesio-taping along with standard care or just standard care alone. Throughout the study, their symptoms will be closely monitored to see if Kinesio-taping makes a difference. This research could provide valuable insights into new ways to manage symptoms for patients facing challenging conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18 years or older.
- • Histologically confirmed intra-abdominal or retroperitoneal malignancy.
- • Diagnosis of malignant bowel obstruction with ascites located below the ligament of Treitz.
- • Persistent severe symptoms (such as pain, bloating, nausea, vomiting) after surgery, medication, or nasogastric tube treatment.
- • Able to communicate in Mandarin or Taiwanese.
- • Capable of providing informed consent.
- Exclusion Criteria:
- • Presence of significant abdominal wounds that preclude application of Kinesio tape.
- • Known allergy or hypersensitivity to Kinesio tape.
- • Pregnancy.
- • Lack of decision-making capacity.
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported